Tung Ming Li, executive director of Dawnrays Pharmaceutical (Holdings) Ltd., a Hong-Kong based manufacturer and seller of non-patented pharmaceutical medicines, has sold 7,848,000 shares, representing 0.9731% stake in the company.
The shares were sold on September 03, 2014, at a price of HKD6.341 ($0.82) per share, for a consideration of HKD49.76 million ($6.42 million).
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Full Name: Mr. Tung Ming Li
Known As: Tung Ming
Gender: Male
Date of Birth / Year: 1949
Citizenship: Nationality | Hong Kong; Domicile | Hong Kong
Home Town: Hong Kong
Languages: English, Chinese
Liquidity Event
5 September 2013 sale of 7.8 million shares in Dawnrays Pharmaceutical (Holdings) Ltd for $6.42 million
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataProfile
Tung Ming Li serves as executive director of Dawnrays Pharmaceutical (Holdings) Ltd. He joined the Group in April 2000 and was appointed to the Board in January 2004. He also holds directorship in Suzhou Dawnrays Pharmaceutical Co., Ltd., Su Zhou Dawnrays Pharmaceutical Science and Technology Co., Ltd. and Dawnrays Pharma (Hong Kong) Ltd., which are all subsidiaries of the Company.
